FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← RXRX · RECURSION PHARMACEUTICALS, INC.
DEFA14AThe Ballot

RECURSION PHARMACEUTICALS, INC. files DEFA14A

Filed Apr 28, 2025 · 1y ago · Accession 0001601830-25-000063

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
RECURSION PHARMACEUTICALS, INC.
Ticker
RXRX
CIK
1601830
Form type
DEFA14A
Filing date
Apr 28, 2025
Report date
—
Document
rxrx_proxystatement2025-ad.htm
Size
2.5 MB

More from RXRX

8-KShareholder VoteJun 18, 20268-KResults of Operations · Reg FD DisclosureMay 6, 202610-QThe RecordMay 6, 2026DEFA14AThe BallotApr 30, 2026DEF 14AThe BallotApr 30, 20268-KExecutive Change · Reg FD DisclosureApr 30, 2026